ArticleBritish journal of cancer2024

Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20.

Iram Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.